Insight Health AI, Inc.

Founded in 2023, Insight Health AI focuses on enhancing the healthcare sector through AI solutions that streamline clinical workflows, improving patient care and operational efficiency. Insight Health AI, Inc. is a company headquartered in Austin, US, specializing in AI-driven solutions for the healthcare industry. Founded in 2023, the company has undertaken two deals to date.

Its latest funding round occurred on April 3, 2026, when it raised USD 11. 00 mn in a Series A round led by Standard Capital, with participation from investors including Eudemian Ventures, Eleven Labs Inc. , Kindred Ventures, and Pear VC. The current valuation of the company stands at USD 58.

56 mn. Insight Health offers an AI Agentic Platform designed for enhancing patient-facing clinical workflows within the healthcare sector. The core product, Aura AI Scribe, allows clinicians to create specialty-specific notes in real-time, reducing documentation time and improving patient interactions. Additional products include AI-driven agents for pre-visit intake, follow-up management, referral processing, phone triage, direct access colonoscopy, and front desk management, all aimed at streamlining administrative tasks and improving patient care efficiency.

The company's solutions are utilized primarily by healthcare providers in the United States and Canada, including solo practitioners and larger healthcare systems. Insight Health operates on a subscription-based model, with its flagship product, Aura AI Scribe, offered at a rate of USD 39. 99 per month or USD 480 annually. Additional team packages are available at USD 79.

99 per clinician per month or USD 960 annually, with enterprise solutions also offered at custom pricing. This structured pricing model allows healthcare providers to adopt services based on their specific operational requirements and the size of their practice. In April 2026, Insight Health AI, Inc. raised USD 11.

00 mn in Series A funding. This funding will support the company's growth and further development of its clinical AI platform. The company is focused on expanding its product offerings and enhancing its existing services. Specific upcoming products and release dates have not been disclosed, but the company aims to strengthen its presence in existing markets while exploring new opportunities in additional geographic regions.